FirstWord HealthTech

FirstWord HealthTech is a reliable source for news and analysis, dedicated to keeping digital health professionals informed about the most recent happenings in the industry worldwide. They deliver quick and trustworthy news about the latest trends in digital health, along with insightful analyses, doctor surveys, and executive interviews for a more comprehensive understanding.

National, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#2676004

United States

#1206323

Health/Health

#16472

Traffic sources

Monthly visitors

Articles

DeepScribe unveils customisation studio to enhance AI scribe

Oct 9, 2023 | firstwordhealthtech.com | Katie Bell

DeepScribe unveiled on Monday a customisation offering allowing clinicians to adapt its artificial intelligence (AI) scribe to their custom workflows. The company said it is the first AI scribe to generate personalised, specialty-specific notes within seconds of completing a visit. "After capturing millions of patient encounters over the last five years, one thing is very clear: not all specialties and not all notes are built equal," remarked CEO Akilesh Bapu.
NuraLogix says Anura platform can be integrated into telehealth offerings

Oct 9, 2023 | firstwordhealthtech.com | Katie Bell

Ref: FirstWord HealthTechPublished: October 09, 2023NuraLogix announced the availability of its Anura telehealth solution for integration into healthcare professionals' telehealth offerings, enabling the real-time assessment of vital signs during video consultation sessions.
Akili appoints Matt Franklin as new CEO

Oct 6, 2023 | firstwordhealthtech.com | Katie Bell

Ref: Business WirePublished: October 06, 2023Akili announced on Friday that Matt Franklin has been appointed to serve as CEO of the digital therapeutics (DTx) company and as a member of its board of directors, effective October 5. He replaced Eddie Martucci who transitioned to the role of board chair, replacing former board chair Chamath Palihapitiya, who resigned from the board on October 4. Franklin's "stepping into the role of CEO comes at an optimal time," said Martucci.
GE HealthCare launches AI feature on certain ultrasound systems for cardiac care

Oct 6, 2023 | firstwordhealthtech.com | Katie Bell

Ref: GE HealthcarePublished: October 06, 2023GE HealthCare on Friday announced the US launch of the artificial intelligence (AI)-driven Caption Guidance feature on its Venue Family point-of-care ultrasound systems. The AI technology provides real-time guidance to users for capturing diagnostic-quality cardiac images.
Friday Five: VC deal flow grows; 7wire’s late-stage booster; Headway turns unicorn; and other stories (6 October 2023)

Oct 5, 2023 | firstwordhealthtech.com | Tina Tan

Ref: Friday Five DeskPublished: October 05, 2023We break down the top healthtech stories trending this week. Megabuck rounds boost Q3 venture dollars tallySeptember marked a return of nine-figure venture investment rounds, which hiked the monthly total dollars raised to over $1 billion for the first time in a while. While VC deal volume was on par with July, September recorded the second highest monthly total dollars raised this year to date, at $1.36 billion.
Veradigm, Holmusk expand behavioural health outcomes partnership

Oct 2, 2023 | firstwordhealthtech.com | Katie Bell

Healthcare data and technology solutions provider Veradigm and Holmusk announced on Monday a new phase in their strategic collaboration that aims to enhance care delivery and improve behavioural health outcomes. Veradigm, formerly Allscripts Healthcare Solutions, led Holmusk’s Series B financing in January that raised $45 million to expand the latter's NeuroBlu database of real-world clinical data for the behavioural health industry.
FDA okays first DNA test to assess predisposition to certain cancers

Oct 2, 2023 | firstwordhealthtech.com | Katie Bell

Ref: FDA, NASDAQ, MorningstarPublished: October 02, 2023The FDA granted de novo marketing authorisation for Invitae's Common Hereditary Cancers Panel test to help detect hundreds of genetic variants associated with an increased risk of developing certain cancers. The in vitro diagnostic test - the first of its kind to be granted marketing authorisation in the US - can also help identify potentially cancer-associated hereditary variants in individuals already diagnosed with cancer.
Renovaro, GEDi Cube to merge

Sep 29, 2023 | firstwordhealthtech.com | Katie Bell

Ref: GlobeNewswire, Fidelity, MarketWatch, DutchNews.nlPublished: September 29, 2023Renovaro Biosciences announced on Friday that it agreed to combine with artificial intelligence (AI) company GEDi Cube in a stock-for-stock acquisition. The transaction, in which GEDi Cube will become a Renovaro subsidiary, has been approved by the companies' boards and is expected to close late in the fourth quarter or early next year, subject to Renovaro stockholder approval.
Friday Five: Medtronic’s CGM leg-up; CMR caps funding flurry; Oracle’s own Alexa for docs; and more (22 Sept 2023)

Sep 21, 2023 | firstwordhealthtech.com | Tina Tan

Ref: Friday Five DeskPublished: September 21, 2023Can Simplera sweeten Medtronic’s diabetes prospects? Medtronic’s latest-generation continuous glucose monitoring (CGM) sensor, Simplera, is making its commercial debut after getting CE mark approval. The disposable CGM is 50% smaller than the Guardian 4, which is currently used as part of the MiniMed 780g automated insulin delivery system.
DeepMind's AlphaMissense AI tool helps predict harmful genetic mutations

Sep 19, 2023 | firstwordhealthtech.com | Katie Bell

DeepMind announced on Tuesday that a study published in Science showed that its new artificial intelligence (AI) model, called AlphaMissense, could classify the effects of missense mutations, in which a single letter of the genetic code changes. The company has made the AlphaMissense catalogue of mutations freely available to the scientific community and open sourced the model code for AlphaMissense.